Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance ...

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...

JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...

After 50 years of life, people who were born preterm had lower odds for some cardiovascular outcomes and similar odds for ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...